Please login to the form below
Nuplazid
This page shows the latest Nuplazid news and features for those working in and with pharma, biotech and healthcare.
Acadia’s drive to extend use of Nuplazid hits a wall
Shares in company down. Acadia Pharmaceutical’s Nuplazid was the first-ever drug to be approved to treat psychosis associated with Parkinson’s disease, but the company’s hopes of extending ... Nuplazid (pimavanserin) is Acadia’s only approved
Latest news
-
Nuplazid backed by FDA panel as first-ever Parkinson's psychosis drug
Some atypical antipsychotic medicines are used to treat more advanced cases of PDP but - unlike Nuplazid - run the risk of aggravating motor symptoms. ... The company is also working on follow-up indications for Nuplazid, including clinical programmes in
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
Latest appointments
-
Srdjan Stankovic joins Acadia Pharmaceuticals
efforts to explore the full potential of Nuplazid to treat patients suffering from additional CNS disorders.” . ... I look forward to leading the team in advancing the promising development programmes with Nuplazid.".
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
-
Senior Medical Writer
-
Competitive salary plus benefits
- Client Services Director- Flexible Working
-
Negotiable
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Director – UK Office
-
Excellent salary and benefits
-
Events Executive
-
DOE
- Account Manager – Healthcare advertising
-
Salary TBC
Subscribe to our email news alerts
- Novartis eyes potential new indication for Cosentyx
- J&J's Tremfya filed for approval in US for psoriatic arthritis
- Envision Pharma Group relocates to support expansion
- Biogen loses another pipeline drug to toxicity concerns
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Half of European cancer drug trials ‘biased’, says BMJ
PMHub
Page & Page
Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...
Latest intelligence
- Report: Customer experience, shaping digital healthcare
- In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
- Encouraging signs in biomarker R&D
- The cancer immunotherapy firms ramping-up biomarker R&D...
- Programmatic methodology and why you should be using it
- What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Quick links
Infographics
